34407-31-3

Basic information

• Product Name: Benzene, 1-bromo-3,4-dimethoxy-2,5-bis(methoxymethoxy)-6-methyl-
• CAS NO: 34407-31-3
• Molecular Formula: C13H19BrO6
• Molecular Weight: 351.194
• Mol File: 34407-31-3.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Benzene, 1-bromo-3,4-dimethoxy-2,5-bis(methoxymethoxy)-6-methyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzene, 1-bromo-3,4-dimethoxy-2,5-bis(methoxymethoxy)-6-methyl-(34407-31-3)
• EPA Substance Registry System: Benzene, 1-bromo-3,4-dimethoxy-2,5-bis(methoxymethoxy)-6-methyl-(34407-31-3)

Safety Data

• Hazardous Substances Data: 34407-31-3(Hazardous Substances Data)

Upstream product

• 605-94-7 2,3-Dimethoxy-5-methyl-1,4-benzoquinone 
• 3066-90-8 2,3-dimethoxy-5-methylbenzene-1,4-diol 
• 30685-17-7 2-bromo-5,6-dimethoxy-3-methylcyclohexane-2,5-diene-1,4-dione 
• 39068-88-7 2,3,4-trimethoxy-6-methylphenol 
• 34417-79-3 2-bromo-5,6-dimethoxy-3-methylbenzene-1,4-diol 
• 107-30-2 chloromethyl methyl ether 

Downstream Products

• 727-81-1 2,3-dimethoxy-5-methyl-6-(3-methyl-2-butenyl)-1,4-benzoquinone 
• 944936-27-0 (tert-butyl){[(2E)-4-(3,4-dimethoxy-2,5-bis(methoxymethoxy)-6-methylphenyl)-2-methylbut-2-enyl]oxy}dimethylsilane 
• 82349-09-5 1-{(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyl-5-[(4-methylphenyl)sulfonyl]tetraconta-2,6,10,14,18,22,26,30,34,38-decaen-1-yl}-3,4-dimethoxy-2,5-bis(methoxymethoxy)-6-methylbenzene 
• 82353-24-0 1-[(2E)-4-bromobut-2-en-1-yl]-3,4-dimethoxy-2,5-bis(methoxymethoxy)-6-methylbenzene 
• 82343-04-2 (2E)-4-(3,4-dimethoxy-2,5-bis(methoxymethoxy)-6-methylphenyl)-2-methylbut-2-en-1-ol 
• 64634-91-9 1-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaen-1-yl]-3,4-dimethoxy-2,5-bis(methoxymethoxy)-6-methylbenzene 
• 303-98-0 ubidecarenone 
• 944936-28-1 1-[(2E)-4-chloro-3-methylbut-2-enyl]-3,4-dimethoxy-2,5-bis(methoxymethoxy)-6-methylbenzene 
• 944936-30-5 1-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-5-(4-chlorophenylsulfonyl)-3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaenyl]-3,4-dimethoxy-2,5-bis(methoxymethoxy)-6-methylbenzene 
• 73875-22-6 (E)-1-(benzenesulfonyl)-4-[3,4-dimethoxy-2,5-bis(methoxymethoxy)-6-methylphenyl]-2-methylbut-2-ene 

Relevant articles and documents

COMPOSITIONS AND METHODS FOR THE PREVENTION AND/OR TREATMENT OF MITOCHONDRIAL DISEASE, INCLUDING FRIEDREICH'S ATAXIA

The disclosure provides therapeutic compounds, compositions (e.g., therapeutic agents or medicaments) and methods for preventing or treating mitochondrial disease such as Friedreich's ataxia in a mammalian subject, reducing risk factors, signs and/or symptoms associated with mitochondrial disease, such as Friedreich's ataxia, and/or reducing the likelihood or severity of mitochondrial disease such as Friedreich's ataxia. The disclosure further provides novel intermediates for the production of said therapeutic compositions. In some instances, the intermediates may themselves by therapeutic agents or prodrugs of therapeutic agents (e.g. reduced forms of the therapeutic compounds).

A new synthesis of coenzyme Q.

-